Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BARNETT A. J. Treatment of severe arterial hypertension: results from long-term use of methonium compounds with and without the addition of reserpine. Australas Ann Med. 1956 Nov;5(4):274–290. doi: 10.1111/imj.1956.5.4.274. [DOI] [PubMed] [Google Scholar]
- CLARKE E., MURPHY E. A. Neurological manifestations of malignant hypertension. Br Med J. 1956 Dec 8;2(5005):1319–1326. doi: 10.1136/bmj.2.5005.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CORCORAN A. C., DUSTAN H. P., PAGE I. H., SCHNECKLOTH R. E. Mecamylamine in treatment of hypertensive disease; observations on an unusual neuromuscular complication. J Am Med Assoc. 1956 Oct 27;162(9):868–875. doi: 10.1001/jama.1956.02970260018006. [DOI] [PubMed] [Google Scholar]
- DEMING Q. B., HODES M. E., EDREIRA J. G., BALTAZAR A. Psychosis, possibly induced by mecamylamine. N Engl J Med. 1957 Apr 18;256(16):739–742. doi: 10.1056/NEJM195704182561604. [DOI] [PubMed] [Google Scholar]
- DUSTAN H. P., SCHNECKLOTH R. E., CORCORAN A. C., PAGE I. H. The effectiveness of long-term treatment of malignant hypertension. Circulation. 1958 Oct;18(4 Pt 1):644–651. doi: 10.1161/01.cir.18.4.644. [DOI] [PubMed] [Google Scholar]
- FRASER J. R., LOWE T. E. Fluid retention during methonium therapy. Australas Ann Med. 1954 Aug;3(3):234–237. doi: 10.1111/imj.1954.3.3.234. [DOI] [PubMed] [Google Scholar]
- HARINGTON M., KINCAID-SMITH P. Psychosis and tremor due to mecamylamine. Lancet. 1958 Mar 8;1(7019):499–501. doi: 10.1016/s0140-6736(58)90810-9. [DOI] [PubMed] [Google Scholar]
- HARINGTON M. The absorption and excretion of hexamethonium salts. Clin Sci. 1953 May;12(2):185–198. [PubMed] [Google Scholar]
- HILDEEN T., KROGSGAARD A. R., VIMTRUP B. Fatal pulmonary changes during the medical treatment of malignant hypertension. Lancet. 1958 Oct 18;2(7051):830–832. doi: 10.1016/s0140-6736(58)90380-5. [DOI] [PubMed] [Google Scholar]
- KINCAID-SMITH P., McMICHAEL J., MURPHY E. A. The clinical course and pathology of hypertension with papilloedema (malignant hypertension). Q J Med. 1958 Jan;27(105):117–153. [PubMed] [Google Scholar]
- KINCAID-SMITH P., SOMERS K., BROWNE J. C. M. Successful pregnancy under treatment for malignant hypertension. Lancet. 1958 Mar 8;1(7019):508–509. doi: 10.1016/s0140-6736(58)90814-6. [DOI] [PubMed] [Google Scholar]
- MASSON G. M., McCORMACK L. J., DUSTAN H. P., CORCORAN A. C. Hypertensive vascular disease as a consequence of increased arterial pressure; quantitative study in rats with hydralazine-treated renal hypertension. Am J Pathol. 1958 Sep-Oct;34(5):817–833. [PMC free article] [PubMed] [Google Scholar]
- McMICHAEL J., MURPHY E. A. Methonium treatment of severe and malignant hypertension. J Chronic Dis. 1955 May;1(5):527–535. doi: 10.1016/0021-9681(55)90064-3. [DOI] [PubMed] [Google Scholar]
- PERRY H. M., Jr, SCHROEDER H. A. The effect of treatment on mortality rates in severe hypertension; a comparison of medical and surgical regimens. AMA Arch Intern Med. 1958 Sep;102(3):418–425. doi: 10.1001/archinte.1958.00030010418011. [DOI] [PubMed] [Google Scholar]
- POUTASSE E. F., DUSTAN H. P. Arteriosclerosis and renal hypertension; indications for aortography in hypertensive patients and results of surgical treatment of obstructive lesions of renal artery. J Am Med Assoc. 1957 Nov 23;165(12):1521–1525. doi: 10.1001/jama.1957.02980300001001. [DOI] [PubMed] [Google Scholar]
- ROSENHEIM M. L. The treatment of severe hypertension. Br Med J. 1954 Nov 20;2(4898):1181–1193. doi: 10.1136/bmj.2.4898.1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROSS J. H., WRIGHT J. A. Successful twin pregnancy after treatment of malignant essential hypertension. Br Med J. 1958 Aug 30;2(5095):545–547. doi: 10.1136/bmj.2.5095.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SCHOTTSTAEDT M. F., SOKOLOW M. The natural history and course of hypertension with papilledema (malignant hypertension). Am Heart J. 1953 Mar;45(3):331–362. doi: 10.1016/0002-8703(53)90147-1. [DOI] [PubMed] [Google Scholar]
- SMIRK F. H. Action of a new methonium compound in arterial hypertension; pentamethylene 1 : 5-bis-n-(n-methyl-pyrrolidinium) bitartrate (M. & B. 2050A). Lancet. 1953 Mar 7;1(6758):457–464. doi: 10.1016/s0140-6736(53)91640-7. [DOI] [PubMed] [Google Scholar]